Patent US4336379A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4336379A Expired / Lapsed US ⏱️ 0.0 years remaining

Isoxazolyl indolamines

Assignee: Sandoz Inc
•
Filing: 1981-03-18
•
Granted: 1982-06-22
•
Expires: 2001-03-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This disclosure describes compounds of the formula <IMAGE> where R1 represents hydrogen, fluoro, chloro, lower alkyl having 1 to 4 carbon atoms or lower alkoxy having 1 to 4 carbon atoms, and R2 represents hydroxy, and R3 and R4 each independently represent lower alkyl as defined above, or R3 and R4 together with N represent <IMAGE> wherein n is 1, 2 or 3, and R5 and R6 each independently represent hydrogen or lower alkyl as defined above, or a pharmaceutically acceptable acid addition salt thereof, which are useful as anti-diabetic agents, in particular as hypoglycemic agents and inhibiting or impeding post-prandial hyperglycemia.

Inventors

  • 👤 Leonard J. Brand
  • 👤 Jeffrey Nadelson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 09:14
CPC Classifications
C; C07; C07D; C07D413/00; C07D413/02; C07D413/04; C07D261/00; C07D261/02; C07D261/06; C07D261/08

Claims Analysis

Total Claims: 22
Claim 1
Independent Claim 97 words
A compound of the formula ##STR11## wherein R 1 represents hydrogen, fluoro, chloro, lower alkyl having 1 to 4 carbon atoms, or lower alkoxy having 1 to 4 carbon atoms, and R 2 represents hydroxy, and R 3 and R 4 each independently represent lower alkyl having 1 to 4 carbon atoms, or R 3 and R 4 together with N represent ##STR12## wherein n is 1, 2 or 3, and R 5 and R 6 each independently represent hydrogen or lower alkyl having 1 to 4 carbon atoms, or a pharmaceutically acceptable acid addition salt thereof.
Claim 2
Dependent Claim 97 words
A compound of the formula ##STR11## wherein R 1 represents hydrogen, fluoro, chloro, lower alkyl having 1 to 4 carbon atoms, or lower alkoxy having 1 to 4 carbon atoms, and R 2 represents hydroxy, and R 3 and R 4 each independently represent lower alkyl having 1 to 4 carbon atoms, or R 3 and R 4 together with N represent ##STR12## wherein n is 1, 2 or 3, and R 5 and R 6 each independently represent hydrogen or lower alkyl having 1 to 4 carbon atoms, or a pharmaceutically acceptable acid addition salt thereof.
Claim 3
Dependent Claim 30 words
A compound of the formula ##STR13## wherein R 1 , R 3 , R 4 & R 5 are as defined in claim 1, or a pharmaceutically acceptable salt thereof.
Claim 4
Dependent Claim 31 words
A compound of the formula ##STR14## where R 2 , R 3 , R 4 , and R 6 are as defined in claim 1, or a pharmaceutically acceptable salt thereof.
Claim 5
Dependent Claim 8 words
The compound of claim 2 which is α-(dimethylaminomethyl)-2-(3-ethyl-5-methyl-4-isoxazolyl)-1H-indole-3-methanol.
Claim 6
Dependent Claim 8 words
The compound of claim 1 which is α-(dimethylaminomethyl)-2-(5-ethyl-3-methyl-4-isoxazolyl)-1H-indole-3-methanol.
Claim 7
Dependent Claim 8 words
The compound of claim 1 which is α-(dimethylaminomethyl)-2-(3-isopropyl-5-methyl-4-isoxazolyl)-1H-indole-3-methanol.
Claim 8
Dependent Claim 8 words
The compound of claim 1 which is α-(pyrrolidinomethyl)-5-fluoro-2-(3-ethyl-5-methyl-4-isoxazolyl)-1H-indole-3-methanol.
Claim 9
Dependent Claim 8 words
The compound of claim 1, which is α-(dimethylaminomethyl)-2-(3-ethyl-4-isoxazolyl)-1H-indole-3-methanol.
Claim 10
Dependent Claim 8 words
The compound of claim 1, which is α-(dimethylaminomethyl)-2-(3,5-dimethyl-4-isoxazolyl)-1H-indole-3-methanol.
Claim 11
Dependent Claim 8 words
The compound of claim 1, which is α-(dimethylaminomethyl)-2-(3,5-dimethyl-4-isoxazolyl)-1H-indole-3-methanol.
Claim 12
Dependent Claim 8 words
The compound of claim 1, which is α-(dimethylaminomethyl)-2-(5-methyl-3-propyl-4-isoxazolyl)-1H-indole-3-methanol.
Claim 13
Dependent Claim 8 words
The compound of claim 1, which is α-(dimethylaminomethyl)-2-(5-methyl-3-t-butyl-4-isoxazolyl)-1H-indole-3-methanol.
Claim 14
Dependent Claim 8 words
The compound of claim 1, which is α-(dimethylaminomethyl)-5-fluoro-2-(3-ethyl-5-methyl-4-isoxazolyl)-1H-indole-3-methanol.
Claim 15
Dependent Claim 8 words
The compound of claim 1, which is α-(diethylaminomethyl)-2-(3-ethyl-5-methyl-4-isoxazolyl)-1H-indole-3-methanol.
Claim 16
Dependent Claim 8 words
The compound of claim 1, which is α-(morpholinomethyl)-2-(3-ethyl-5-methyl-4-isoxazolyl)-1H-indole-3-methanol.
Claim 17
Dependent Claim 8 words
The compound of claim 1, which is α-(pyrrolidinomethyl)-2-(3-ethyl-5-methyl-4-isoxazolyl)-1H-indole-3-methanol.
Claim 18
Dependent Claim 8 words
The compound of claim 1, which is α-(piperidinomethyl)-2-(3-ethyl-5-methyl-4-isoxazolyl)-1H-indole-3-methanol.
Claim 19
Dependent Claim 8 words
The compound of claim 1, which is α-(dimethylaminomethyl)-5-fluoro-2-(3,5-dimethyl-4-isoxazolyl)-1H-indole-3-methanol.
Claim 20
Dependent Claim 8 words
The compound of claim 1, which is α-(dimethylaminomethyl)-5-fluoro-2-(3-methyl-5-ethyl-4-isoxazolyl)-1H-indole-3-methanol.
Claim 21
Dependent Claim 8 words
The compound of claim 1, which is α-(pyrrolidinomethyl)-5-fluoro-2-(5-ethyl-3-methyl-4-isoxazolyl)-1H-indole-3-methanol.
Claim 22
Dependent Claim 8 words
The compound of claim 1, which is α-(pyrrolidinomethyl)-5-fluoro-2-(3,5-dimethyl-4-isoxazolyl)-1H-indole-3-methanol.

References Cited (Backward Citations)

US3467670A Cited
US3466287A Cited
US4072675A Cited
US4021431A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-06-21 1985-12-21 1986-06-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-06-21 1989-12-21 1990-06-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-06-21 1993-12-21 1994-06-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag